BERANDA RESMI
ARC Institute
← Katalog Appraisal
TAPublishedBlood and immune system conditions / Blood and bone marrow cancers· 2024-07-10
TA987

Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (terminated appraisal)

0 item

Rekomendasi numbered